Getting to the heart of the matter - Are two agents really better than one for the treatment of staphylococcal infective endocarditis?

The recently published 2023 update from the European Society of Cardiology (ESC) regarding the management of infective endocarditis introduces many welcome changes. Commendable are the transition towards outpatient care and the adoption of oral therapeutic regimens for carefully selected and clinically stable patients [1]. However, the management of these patients still presents numerous challenges, particularly in the context of selecting the most appropriate antimicrobial regimen.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Tags: Perspective Source Type: research